1-13 of 13
mantle-cell lymphoma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis

Kang Le, Jing Sun, Hunain Khawaja, Maho Shibata, Sanjay B. Maggirwar, Mitchell R. Smith, Mamta Gupta
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2863–2878.
https://doi.org/10.1182/bloodadvances.2020003871
Published: 2021
Includes: Supplemental data
Journal Articles

Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma

Clinical Trials & Observations
Constantine S. Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Tycel J. Phillips, Won Seog Kim, Simon Rule, Siminder Kaur Atwal, Rachel Wei, William Novotny, Jane Huang, Michael Wang, Judith Trotman
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2577–2585.
https://doi.org/10.1182/bloodadvances.2020004074
Published: 2021
Includes: Supplemental data
Journal Articles

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival

Clinical Trials & Observations
Ingrid Glimelius, Karin E. Smedby, Alexandra Albertsson-Lindblad, Michael J. Crowther, Sandra Eloranta, Mats Jerkeman, Caroline E. Weibull
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1638–1647.
https://doi.org/10.1182/bloodadvances.2020003645
Published: 2021
Includes: Supplemental data
Journal Articles

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma

Clinical Trials & Observations
Diego Villa, Laurie H. Sehn, Kerry J. Savage, Cynthia L. Toze, Kevin Song, Wendie D. den Brok, Ciara L. Freeman, David W. Scott, Alina S. Gerrie
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3486–3494.
https://doi.org/10.1182/bloodadvances.2020002068
Published: 2020
Includes: Supplemental data
Journal Articles

Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis

Holly A. Hill, Xinyue Qi, Preetesh Jain, Krystle Nomie, Yucai Wang, Shouhao Zhou, Michael L. Wang
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2927–2938.
https://doi.org/10.1182/bloodadvances.2019001350
Published: 2020
Includes: Supplemental data
Journal Articles

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

Clinical Trials & Observations
Reid W. Merryman, Natasha Edwin, Robert Redd, Jad Bsat, Matthew Chase, Ann LaCasce, Arnold Freedman, Caron Jacobson, David Fisher, Samuel Ng, Jennifer Crombie, Austin Kim, Oreofe Odejide, Matthew S. Davids, Jennifer R. Brown, Heather Jacene, Amanda Cashen, Nancy L. Bartlett, Neha Mehta-Shah, Armin Ghobadi, Brad Kahl, Robin Joyce, Philippe Armand, Eric Jacobsen
Journal: Blood Advances
Blood Adv (2020) 4 (5): 858–867.
https://doi.org/10.1182/bloodadvances.2019001355
Published: 2020
Includes: Supplemental data
Journal Articles

Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma

Manali Kamdar, Hongli Li, Robert W. Chen, Lisa M. Rimsza, Michael L. Leblanc, Timothy S. Fenske, Thomas C. Shea, Paul M. Barr, Tycel J. Phillips, John P. Leonard, Brad S. Kahl, Jonathan W. Friedberg, Sonali M. Smith
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3132–3135.
https://doi.org/10.1182/bloodadvances.2019000526
Published: 2019
Journal Articles

Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma

Clinical Trials & Observations
Matthew S. Ning, Chelsea C. Pinnix, Bhavana V. Chapman, Jillian R. Gunther, Sarah A. Milgrom, Joseph D. Khoury, Preetesh Jain, Wendy Y. Chen, Onyeka N. Oriabure, Maria R. Badillo, L. Michael Wang, Bouthaina S. Dabaja
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2035–2039.
https://doi.org/10.1182/bloodadvances.2019030858
Published: 2019
Journal Articles

Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies

Clinical Trials & Observations
Jess F. Peterson, Linda B. Baughn, Rhett P. Ketterling, Beth A. Pitel, Stephanie A. Smoley, George Vasmatzis, James B. Smadbeck, Patricia T. Greipp, Abhishek A. Mangaonkar, Carrie A. Thompson, Sameer A. Parikh, Dong Chen, David S. Viswanatha
Journal: Blood Advances
Blood Adv (2019) 3 (8): 1298–1302.
https://doi.org/10.1182/bloodadvances.2019031450
Published: 2019
Includes: Supplemental data
Journal Articles

Lee J, Zhang LL, Wu W, et al. Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma. Blood Adv. 2018;2(16):2039-2051.

Journal: Blood Advances
Blood Adv (2018) 2 (20): 2588.
https://doi.org/10.1182/bloodadvances.2018026344
Published: 2018
Journal Articles

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma

Jimmy Lee, Liang Leo Zhang, Wenjun Wu, Hui Guo, Yan Li, Madina Sukhanova, Girish Venkataraman, Shengjian Huang, Hui Zhang, Mir Alikhan, Pin Lu, Ailin Guo, Natalie Galanina, Jorge Andrade, Michael L. Wang, Y. Lynn Wang
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2039–2051.
https://doi.org/10.1182/bloodadvances.2018016048
Published: 2018
Includes: Supplemental data
Journal Articles

Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma

Clinical Trials & Observations
Agata M. Wasik, Chenglin Wu, Larry Mansouri, Richard Rosenquist, Qiang Pan-Hammarström, Birgitta Sander
Journal: Blood Advances
Blood Adv (2018) 2 (6): 621–625.
https://doi.org/10.1182/bloodadvances.2017014860
Published: 2018
Includes: Supplemental data
Journal Articles

Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma

Hanna Karvonen, David Chiron, Wilhelmiina Niininen, Sara Ek, Mats Jerkeman, Elaheh Moradi, Matti Nykter, Caroline A. Heckman, Olli Kallioniemi, Astrid Murumägi, Daniela Ungureanu
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2257–2268.
https://doi.org/10.1182/bloodadvances.2017010215
Published: 2017
Includes: Supplemental data